Advanced search
Publication Cover
Drug Delivery Volume 25, 2018 - Issue 1
Submit an article Journal homepage
1,873
Views
22
CrossRef citations to date
0
Altmetric
Research Article

A local drug delivery system based on visible light-cured glycol chitosan and doxorubicin⋅hydrochloride for thyroid cancer treatment in vitro and in vivo

Youngbum YooDepartment of Surgery, School of Medicine, The Konkuk University, Seoul, Republic of Korea; View further author information
,
Sun-Jung YoonDepartment of Orthopedic Surgery, Research Institute of Clinical Medicine of Chonbuk National University, Biomedical Research Institute of Chonbuk National University Hospital, Jeonju, Republic of Korea; View further author information
,
So Yeon KimDepartment of Dental Hygiene College of Health Sciences, Cheongju University, Cheongju, Republic of Korea; View further author information
,
Deok-Won LeeDepartment of Oral & Maxillofacial Surgery, Kyung Hee University Dental Hospital at Gangdong Kyung Hee University, Seoul, Republic of Korea; View further author information
,
Sewook UmDepartment of Veterinary Surgery, College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea; View further author information
,
Hoon HyunDepartment of Biomedical Sciences, Chonnam National University Medical School, Gwangju, Republic of Korea; View further author information
,
Sung Ok HongDepartment of Dentistry, Catholic Kwandong University, School of Medicine, International St. Mary’s Hospital, Incheon, Republic of Korea; View further author information
&
Dae Hyeok YangInstitute of Cell and Tissue Engineering, College of Medicine, The Catholic University of Korea, Seoul, Republic of KoreaCorrespondence[email protected]
View further author information
 show all
Pages 1664-1671 | Received 28 May 2018, Accepted 29 Jul 2018, Published online: 05 Sep 2018

References

  • Agudelo D, Bourassa P, Bérubé G, Tajmir-Riahi HA. (2014). Intercalation of antitumor drug doxorubicin and its analogue by DNA duplex: structural features and biological implications. Int J Biol Macromol 66:144–50.
  • Bhattarai N, Gunn J, Zhang M. (2010). Chitosan-based hydrogels for controlled, localized drug delivery. Adv Drug Deliv Rev 62:83–99.
  • Grant CS. (2015). Recurrence of papillary thyroid cancer after optimized surgery. Gland Surg 4:52–62.
  • He M, Sui J, Chen Y. (2017). Localized multidrug co-delivery by injectable self-crosslinking hydrogel for synergistic combinational chemotherapy. J Mater Chem B 5:4852–62.
  • Hu J, Hou Y, Park H, et al. (2012). Visible light crosslinkable chitosan hydrogels for tissue engineering. Acta Biomater 8:1730–8. (202).
  • Hyun H, Park MH, Lim W, et al. (2018). Injectable visible light-cured glycol chitosan hydrogels with controlled release of anticancer drugs for local cancer therapy in vivo: a feasible study. Artif Cells Nanomed Biotechnol 1. DOI: 10.1080/21691401.2018.1470529.
  • Ke W, Zhao Y, Huang R, et al. (2008). Enhanced oral bioavailability of doxorubicin in a dendrimer drug delivery system. J Pharm Sci 97:2208–16.
  • Kuen C, Fakurazi S, Othman S, Masarudin M. (2017). Increased loading, efficacy and sustained release of silibinin, a poorly soluble drug using hydrophobically-modified chitosan nanoparticles for enhanced delivery of anticancer drug delivery systems. Nanomaterials (Basel) 7:379.
  • Li S, Zhang D, Sheng S, Sun H. (2017). Targeting thyroid cancer with acid-triggered release of doxorubicin from silicon dioxide nanoparticles. Int J Nanomedicine 12:5993–6003.
  • Matuszczyk A, Petersenn S, Bockisch A, et al. (2008). Chemotherapy with doxorubicin in progressive medullary and thyroid carcinoma of the follicular epithelium. Horm Metab Res 40:210–13.
  • Nguyen QT, Lee EJ, Huang MG, et al. (2015). Diagnosis and treatment of patients with thyroid cancer. Am Health Drug Benefits 8:30–40.
  • Parhi R. (2017). Cross-linked hydrogel for pharmaceutical applications: a review. Adv Pharm Bull 7:515–30.
  • Pommier Y, Leo E, Zhang H, Marchand C. (2010). DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol 17:421–33.
  • Qi Y, Min H, Mujeeb A, et al. (2018). Injectable hexapeptide hydrogel for localized chemotherapy prevents breast cancer recurrence. ACS Appl Mater Interfaces 10:6972–81.
  • Rocca JD, Liu D, Lin W. (2012). Are high drug loading nanoparticles the next step forward for chemotherapy? Nanomedicine (Lond) 7:303–5.
  • De Souza R, Zahedi P, Allen CJ, Piquette-Miller M. (2010). Polymeric drug delivery systems for localized cancer chemotherapy. Drug Deliv 17:365–75.
  • Sriamornsak P, Thirawong N, Weerapol Y, et al. (2007). Swelling and erosion of pectin matrix tablets and their impact on drug release behavior. Eur J Pharm Biopharm 67:211–19.
  • Yang DH, Seo DI, Lee D-W, et al. (2017). Preparation and evaluation of visible light cured glycol chitosan hydrogel dressing containing dual growth factors for accelerated wound healing. J Ind Eng Chem 53:360–70.
  • Yang F, Teves SS, Kemp CJ, Henikoff S. (2014). Doxorubicin, DNA torsion, and chromatin dynamics. Biochim Biophys Acta 1845:84–9.
  • Yoon S-J, Hyun H, Lee D-W, Yang DH. (2017). Visible light-cured glycol chitosan hydrogel containing a beta-cyclodextrin-curcumin inclusion complex improves wound healing in vivo. Molecules 22:1513.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.